Drug companies and their allies over the past year have filed a slew of lawsuits challenging the Medicare drug-price ... U.S.

Tom Quaadman, Chamber GIPC The White House on Thursday announced that it has finalized negotiations with the manufacturers of the 10 drugs ... program, “avoid the harmful consequences of price ...

Had the program ... to the drug manufacturers, the U.S. Chamber of Commerce and industry trade group PhRMA also sued the administration over the legislation, but all legal challenges have failed thus ...

Chambers of commerce exist all over the world ... may or may not be affiliated with the U.S. Chamber of Commerce through a Federation Partnership Program. The national chamber tends to support ...

The Harris campaign website said the vice president is committed to bringing down drug prices "by taking on pharmacy ...

As a result of the Price Negotiation Program and the drug pricing changes to be expected over the next few years, health plans are encouraged to review closely the financial terms of their ...

1 These drugs are considered some of the most expensive and frequently dispensed throughout the Medicare program. According to CMS, the negotiated prices will allow Medicare patients with ...

Previously, the U.S. government was not permitted to negotiate with Big Pharma over drug prices, though private ... challenging the premium stabilization program, alleging that it should have ...

Frank Pallone, D-N.J., who is the ranking Democrat on the House Energy & Commerce ... program does not take aim at pharmacy benefit managers. PBMs, pharma play blame game over drug pricing at ...

But the pharmaceutical industry has decried the effort as “price setting” that will over time become a drag on drug research and ... to define her own economic program independent of Biden ...

The negotiated rates represent a savings from 38 percent to 79 percent over the 2023 list prices of the drugs, which were some of the priciest in Medicare. But Medicare doesn’t pay the full list ...

Medicare officials on Thursday unveiled the results of the program’s first 10 drug price negotiations, despite the industry’s two-decade, multimillion-dollar lobbying campaign and barrage of l ...